Search Results

0 results for 'Goodwin Procter'

You can use to get even better search results
Cohen v. Viray, 08-3860-cv
Publication Date: 2010-10-01
Practice Area: Business Law
Industry:
Court: U.S. District Court, Southern District
Judge: Before: Hall, Livingston, and Chin,* C.JJ.
Attorneys:
For plaintiff: GARY D. SESSER (William F. Sondericker, Laura Anne Reeds, and Christopher J. Young, on the brief), Carter Ledyard & Milburn LLP, New York, New York, for Intervenor-Appellant D. David Cohen. THOMAS G. AMON, Law Offices of Thomas G. Amon, New York, New York, and Brian J. Robbins, and Gregory E. Del Gaizo, on the brief, Robbins Umeda LLP, San Diego, California, for Plaintiff-Appellee Alvin Viray, Derivatively on Behalf of DHB Industries, Inc.
For defendant: ERIC RIEDER (David P. Kasakove and Chris M. LaRocco, of counsel, on the brief), Bryan Cave LLP, New York, New York, for Defendant-Appellee DHB Industries, Inc., now known as Point Blank Solutions, Inc.. MARK HOLLAND (Mary K. Dulka, on the brief), Goodwin Procter LLP, New York, New York, for Defendants-Appellees Barry Berkman, Cary Chasin, Gary Nadelman, and Jerome Krantz. JEROME GOTKIN, Mintz Levin Cohn Ferris Glovsky and Popeo, P.C., New York, New York, for Defendant-Appellee David H. Brooks. STEVEN G. KOBRE (Francisco J. Navarro, on the brief), Kobre & Kim LLP, New York, New York, for Defendant-Appellee Dawn M. Schlegel. RACHEL PENSKI, Milbank, Tweed, Hadley & McCloy LLP, New York, New York, for Defendants-Appellees David Brooks International, Inc., Elizabeth Brooks International, Inc., and Andrew Brooks International, Inc.
Case number: 08-3860-cv

Cite as: Cohen v. Viray, 08-3860-cv, NYLJ 1202472745889, at *1 (2d Cir, Decided September 30, 2010)Before: Hall, Livingston, and Chin,* C.JJ.p class="decid

Bank of America Settles Fannie Mae, Freddie Mac Mortgage Claims for $2.8 Billion
Publication Date: 2011-01-03
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

The deal, which comes before the agency that oversees Fannie and Freddie filed any suit against BofA, is the best indicator to date of the potential value of buyback claims against issuers of mortgage-backed securities. The bad news for investors? Analysts say BofA's $2.8 billion payout is a bargain for the bank.

Weil Gotshal Scores for Merck in Singulair Patent Dispute with Teva
Publication Date: 2009-08-19
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Weil IP star Matt Powers has taken his lumps in recent weeks for his unsuccessful defense of Microsoft in the Texas trial that resulted in a $290 million verdict against the software giant. But he sure came through for Merck. In an opinion that sent the company's shares soaring, a New Jersey judge barred Teva from introducing a generic version of Merck's allergy blockbuster.

Who's the Splashiest Plaintiffs Lawyer in the Mortgage-Backed Securities Game? Ex-Dewey Insurance Litigator David Grais
Publication Date: 2010-03-22
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Two new California state court suits filed by Grais were the subject of a Sunday New York Times column that noted his strategy of steering clear of hard-to-prove fraud allegations. But there are still a raft of defense firms standing between Grais and a big payday.

February 16, 2005 |

Latest Merger Has Midsize D.C. Firms Pondering the Altar

It began, perhaps appropriately enough, at Arabelle, a romantic Manhattan restaurant best known for its role as a Sex and the City set.
8 minute read
In War Over Marvel Superheroes, Paul Hastings Wins Dismissal of Stan Lee Media's $2 Billion Derivative Suit
Publication Date: 2010-04-05
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

If the litigation over rights to the superheroes Stan Lee created at Marvel Entertainment were a comic book, Marvel counsel David Fleischer of Paul Hastings would be wearing tights and a cape.

March 03, 2004 |

Who's Recusing and Who's Refusing?

The continuing furor over Justice Antonin Scalia's hunting trip with Vice President Dick Cheney has cast a spotlight on the murky world of Supreme Court recusals, where justices decide to recuse -- or not -- without review by their fellow justices or others. A Legal Times survey sheds some light on who steps aside most often, who stays put, and which cases have prompted the judicial do-si-do.
9 minute read
Federal Circuit Reverses Lower Court, Hands Sanofi-Aventis Win in Fight over Generic Versions of Cancer Drug
Publication Date: 2009-09-10
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

The appellate ruling comes too late to keep generic manufacturers of the colon cancer drug Eloxatin out of the market, but the Federal Circuit found that a lower court judge interpreted Sanofi's patent incorrectly when he cleared the way for its rivals.

March 01, 2004 |

No Rhyme or Reason to Justices' Recusals

Justice Antonin Scalia's motivation for recusing himself in a case involving the Republic of Croatia may have been revealed in a financial disclosure form he filed: Scalia reported that he had been reimbursed by Croatia for a trip to meet Croatian judges in July 2002.
9 minute read

TRENDING STORIES

    Resources